Investor's Business Daily flipped this story into Financial & Business News•1476d
Shares of Fate Therapeutics (FATE) popped Friday after the biotech company announced a deal with Johnson & Johnson (JNJ) to develop cancer …
Investor's Business Daily flipped this story into Financial & Business News•1476d